OCWP
AZN icon

Owl Creek Wealth Partners’s AstraZeneca AZN Stock Holding History

Owl Creek Wealth Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$235K Buy
1,241
+116
+10% +$21.8K 0.07% 95
2026
Q1 		$222K Buy
+1,125
New +$217K 0.08% 91

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $148B AUM
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return

Owl Creek Wealth Partners's AZN Position: Q2 2026 in Review

Owl Creek Wealth Partners increased its AstraZeneca (AZN) stake by 10% in Q2 2026, buying an estimated $21.8K and bringing the position to 1,241 shares worth $235K. The position accounts for 0.07% of the portfolio, ranked #95.

Owl Creek Wealth Partners first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. 1,425 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Owl Creek Wealth Partners held 1,241 shares of AstraZeneca worth $235K as of Q2 2026.
  • Owl Creek Wealth Partners bought 116 AstraZeneca shares in Q2 2026, an estimated $21.8K.
  • AstraZeneca made up 0.07% of Owl Creek Wealth Partners's portfolio in Q2 2026, its #95 holding.
  • Owl Creek Wealth Partners first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
  • 1,425 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Owl Creek Wealth Partners's 13F filing for Q2 2026, filed 20 Jul 2026.